» Articles » PMID: 38781453

Stereotactic Radioablation for Recurrent or Nearly Incessant Slow Ventricular Tachycardia Treatment

Overview
Authors
Affiliations
Soon will be listed here.
References
1.
Mehrhof F, Huttemeister J, Tanacli R, Bock M, Bogner M, Schoenrath F . Cardiac radiotherapy transiently alters left ventricular electrical properties and induces cardiomyocyte-specific ventricular substrate changes in heart failure. Europace. 2024; 26(1). PMC: 10803027. DOI: 10.1093/europace/euae005. View

2.
Haskova J, Jedlickova K, Cvek J, Knybel L, Neuwirth R, Kautzner J . Oesophagopericardial fistula as a late complication of stereotactic radiotherapy for recurrent ventricular tachycardia. Europace. 2022; 24(6):969. DOI: 10.1093/europace/euab326. View

3.
Carbucicchio C, Andreini D, Piperno G, Catto V, Conte E, Cattani F . Stereotactic radioablation for the treatment of ventricular tachycardia: preliminary data and insights from the STRA-MI-VT phase Ib/II study. J Interv Card Electrophysiol. 2021; 62(2):427-439. PMC: 8490832. DOI: 10.1007/s10840-021-01060-5. View

4.
Grehn M, Mandija S, Miszczyk M, Krug D, Tomasik B, Stickney K . STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in.... Europace. 2023; 25(4):1284-1295. PMC: 10105846. DOI: 10.1093/europace/euac238. View

5.
van der Ree M, Dieleman E, Visser J, Planken R, Boekholdt S, de Bruin-Bon R . Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial. Europace. 2023; 25(3):1015-1024. PMC: 10062344. DOI: 10.1093/europace/euad020. View